Markers and tissue resources for melanoma: meeting report
- PMID: 17108101
- DOI: 10.1158/0008-5472.CAN-06-0921
Markers and tissue resources for melanoma: meeting report
Abstract
The Markers and Tissue Resources for Melanoma meeting convened by the Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, Specialized Programs of Research Excellence at the Organ Systems Branch of the National Cancer Institute (NCI), and the Melanoma Research Foundation was held in Gaithersburg, MD on October 2005. The meeting reviewed the current status of biomarkers for early- and advanced-stage melanoma and addressed some of the challenges scientists and clinicians face as they unravel the biology of melanoma and try to apply these findings to patient care. Specifically, the participants focused on molecular changes associated with melanoma progression, potential diagnostic and prognostic markers emerging from molecular profiling studies, and new treatment targets for current and future clinical trials. They also highlighted the ongoing challenges about translational research in melanoma, including availability of tissue resources, and summarized the status of nevus and melanoma tissue microarrays, recently developed as a collaborative project between the melanoma research community and the NCI. The meeting report is intended to provide a perspective on emerging scientific approaches in translational research that can enhance the progress in discovery and validation of markers for melanoma. (Cancer Res 2006; 66(22): 10652-7).
Similar articles
-
Emerging Biomarkers in Cutaneous Melanoma.Mol Diagn Ther. 2018 Apr;22(2):203-218. doi: 10.1007/s40291-018-0318-z. Mol Diagn Ther. 2018. PMID: 29411301 Review.
-
Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study.J Cutan Pathol. 2010 Apr;37 Suppl 1:41-7. doi: 10.1111/j.1600-0560.2010.01505.x. J Cutan Pathol. 2010. PMID: 20482674
-
The NCI All Ireland Cancer Conference.Oncologist. 1999;4(4):275-277. Oncologist. 1999. PMID: 10545862
-
Future perspectives in melanoma research. Meeting report from the "Melanoma Research: a bridge Naples-USA. Naples, December 6th-7th 2010".J Transl Med. 2011 Mar 26;9:32. doi: 10.1186/1479-5876-9-32. J Transl Med. 2011. PMID: 21439082 Free PMC article.
-
Liquid biomarkers in melanoma: detection and discovery.Mol Cancer. 2018 Jan 17;17(1):8. doi: 10.1186/s12943-018-0757-5. Mol Cancer. 2018. PMID: 29343260 Free PMC article. Review.
Cited by
-
Evaluation of melanogenesis in A-375 cells in the presence of DMSO and analysis of pyrolytic profile of isolated melanin.ScientificWorldJournal. 2012;2012:854096. doi: 10.1100/2012/854096. Epub 2012 May 2. ScientificWorldJournal. 2012. PMID: 22654640 Free PMC article.
-
Biomarkers of cancer metastasis through the lymphovascular system: future perspectives.Clin Exp Metastasis. 2012 Oct;29(7):861-4. doi: 10.1007/s10585-012-9522-0. Epub 2012 Aug 15. Clin Exp Metastasis. 2012. PMID: 22892756
-
Progression of cutaneous melanoma: implications for treatment.Clin Exp Metastasis. 2012 Oct;29(7):775-96. doi: 10.1007/s10585-012-9521-1. Epub 2012 Aug 15. Clin Exp Metastasis. 2012. PMID: 22892755 Free PMC article. Review.
-
A novel biomarker harvesting nanotechnology identifies Bak as a candidate melanoma biomarker in serum.Exp Dermatol. 2011 Jan;20(1):29-34. doi: 10.1111/j.1600-0625.2010.01187.x. Exp Dermatol. 2011. PMID: 21158936 Free PMC article.
-
Increased shedding of HU177 correlates with worse prognosis in primary melanoma.J Transl Med. 2010 Feb 23;8:19. doi: 10.1186/1479-5876-8-19. J Transl Med. 2010. PMID: 20178639 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical